The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Directors' Dealing

27 Feb 2020 11:22

RNS Number : 3668E
Craven House Capital PLC
27 February 2020
 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

Craven House Capital plc

 

("Craven House" or the "Company")

 

Issue of Equity and Directors' Dealing

 

 

The Company announces that Balbir Bindra and Calum Morrison have each been issued 4,904 new ordinary shares ("New Ordinary Shares") as per the terms of their respective appointment letters.

 

As a result of this issue, Balbir Bindra will hold 14,440 Ordinary Shares, representing 0.5% per cent of the Company's issued share capital.

 

As a result of this issue, Calum Morrison will hold 7,356 Ordinary Shares, representing 0.2% per cent of the Company's issued share capital.

 

 

Admission of the New Ordinary Shares to trading on AIM and Total Voting Rights

 

Application will be made for admission of the 9,808 New Ordinary Shares to be issued on the AIM Market of the London Stock Exchange, which is expected to take place at 8.00 a.m. on or around 4 March 2020 ("Admission").

 

The New Ordinary Shares will, when issued, be credited as fully paid and will rank equally in all respects with the existing Ordinary Shares, including the right to receive any dividend or other distribution declared, made or paid after Admission.

 

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following Admission will consist of 3,063,589 Ordinary Shares of $1.00 with voting rights attached (one vote per Ordinary Share). There are no Ordinary Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the DTRs.

 

~ Ends ~

 

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.Sparkadvisorypartners.com

 

 

 

 

Tel: 0203 368 3550

 

 

 

About Craven House Capital:

 

The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.

 

 

PDMR Notifications

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Balbir Bindra

2. Calum Morrison

2.

Reason for the Notification

a)

Position/status

1. Non-Executive Director

2. Non-Executive Director

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Craven House Capital PLC

b)

LEI

213800NY9RH8O1B72D27

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of $1.0

Identification code

GB00BD4FQ360

b)

Nature of the Transaction

Issue of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. $0

2. $0

1. 4,904

2. 4,904

d)

Aggregated information

Aggregated volume / price

Aggregate volume: 9,808

Aggregated price: $0

e)

Date of the transaction

27 February 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPPUUPPUPUGGM
Date   Source Headline
18th Feb 20207:00 amRNSPlacing to raise $2m
13th Feb 20203:37 pmRNSTR-1: notification of major holdings
12th Feb 20202:05 pmRNSSecond Price Monitoring Extn
12th Feb 20202:00 pmRNSPrice Monitoring Extension
12th Feb 20207:00 amRNSPlacing to raise $1.9m
13th Jan 20207:00 amRNSCompletion of purchase of IIU, Inc. from LMFA
7th Jan 20202:03 pmRNSTR-1: Notification of major holdings
6th Jan 202010:54 amRNSResult of AGM
3rd Jan 20207:00 amRNSLoan Agreement with LMFA
2nd Jan 20207:00 amRNSPortfolio and NAV update
29th Nov 201910:57 amRNSTR-1: Notification of major holdings
28th Nov 20195:58 pmRNSAnnual Results for year ended 31 May 2019
25th Nov 20192:28 pmRNSTR-1: notification of major holdings
21st Nov 20191:08 pmRNSTR-1: notification of major holdings
20th Nov 20192:04 pmRNSTR-1: notification of major holdings
15th Nov 20192:37 pmRNSIssue of Equity
30th Oct 20193:56 pmRNSTR-1: notification of major holdings
21st Oct 20194:41 pmRNSSecond Price Monitoring Extn
21st Oct 20194:35 pmRNSPrice Monitoring Extension
17th Oct 20199:55 amRNSIssue of Equity
1st Oct 201911:15 amRNSTR-1: Form for notification of major holding
27th Sep 20192:18 pmRNSTR-1: Notification of major holdings
26th Sep 201911:52 amRNSPotential Acquisition
25th Sep 20194:41 pmRNSSecond Price Monitoring Extn
25th Sep 20194:35 pmRNSPrice Monitoring Extension
30th Aug 20195:18 pmRNSCraven House increases stake in LMFA
30th Aug 20197:00 amRNSIssue of Equity
22nd Jul 20194:56 pmRNSChange of Company Secretary, Issue of Equity
3rd Jul 201912:24 pmRNSYear-end Update and Financial Calendar
10th Jun 20195:17 pmRNSCraven House increases stake in LMFA
6th Jun 201912:22 pmRNSCraven House increases stake in LM Funding America
27th Feb 20195:15 pmRNSInterim Results
17th Jan 20191:54 pmRNSCompletion of sale of subsidiary
4th Jan 201911:22 amRNSResult of AGM and GM
20th Dec 20181:25 pmRNSPotential sale of subsidiary
12th Dec 20188:00 amRNSReduction in Capital Update
11th Dec 20184:34 pmRNSPosting of Annual Report and Notice of AGM
29th Nov 20181:36 pmRNSAnnual Results for year ended 31 May 2018
14th Nov 20187:00 amRNSAcquisition of shares in LM Funding America, Inc.
17th Oct 20188:13 amRNSBoard Change
24th Aug 20184:20 pmRNSResult of General Meeting
9th Aug 201810:02 amRNSNotice of General Meeting
28th Jun 20182:05 pmRNSSecond Price Monitoring Extn
28th Jun 20182:00 pmRNSPrice Monitoring Extension
11th Jun 20183:13 pmRNSSettlement of Legal Dispute
1st Jun 20182:49 pmRNSAcquisition of insurance broker in United States
24th Apr 20184:08 pmRNSDLC Holdings Update
20th Mar 20187:00 amRNSUpdate: DLC Holdings and Qeton
28th Feb 20187:00 amRNSInterim Results
7th Feb 20184:33 pmRNSFMCD Ltd partially repay Convertible Loan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.